- Home
- IVVD vs SOR Comparison
IVVD vs SOR Comparison
Compare IVVD & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IVVD | SOR |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | 100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.1M | 391.5M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | IVVD | SOR |
|---|---|---|
| Price | $1.55 | $49.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 10.5K |
| Earning Date | 04-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,384,000.00 | N/A |
| Revenue This Year | $107.86 | N/A |
| Revenue Next Year | $146.53 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $38.66 |
| 52 Week High | $3.07 | $50.41 |
Technical Indicators
Market Signals| Indicator | IVVD | SOR |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 52.35 |
| Support Level | $1.50 | $47.72 |
| Resistance Level | $1.66 | $49.50 |
| Average True Range (ATR) | 0.15 | 0.86 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 25.35 | 36.28 |
Price Performance
Historical ComparisonAbout IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.